Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $9.8000 (-0.51%) ($9.5000 - $9.9900) on Sun. Feb. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.69% (three month average) | RSI | 24 | Latest Price | $9.8000(-0.51%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | AUTL declines -7.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting AUTL price | AUTL will decline at least -2.345% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.345% (StdDev 4.69%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-12.95(-232.14%) | Resistance Level | $10.93 | 5 Day Moving Average | $9.77(0.31%) | 10 Day Moving Average | $9.9(-1.01%) | 20 Day Moving Average | $10.93(-10.34%) | To recent high | -39.8% | To recent low | 1.4% | Market Cap | $N/A | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |